Stock IBP INDO-BANGLA PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Indo-Bangla Pharmaceuticals Limited

Equities

IBP

BD0494IBPL08

Pharmaceuticals

End-of-day quote Dhaka S.E.
Other stock markets
 06:00:00 2024-07-09 pm EDT 		5-day change 1st Jan Change
15.4 BDT -2.53% Intraday chart for Indo-Bangla Pharmaceuticals Limited +10.79% -18.52%
May. 13 Indo-Bangla Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI
Feb. 11 Indo-Bangla Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI

Business Summary

Indo-Bangla Pharmaceuticals Limited is a Bangladesh-based pharmaceutical company. The Company is engaged in manufacturing and selling all kinds of medicines, medical preparations, drugs & chemicals (Human Health). It manufactures more than 450 generic drugs for 5,300 registered brands. It produces more than 90 brands. The Company’s pharma portfolio encompasses various categories, including analgesics, respiratory, cardiovascular, central nervous system, dermatology, and gastrointestinal. Its products include Tablet I-Pedom 10mg, Tablet Indophylline 100mg, Tablet sulbumol plus 4.0mg, Tablet Sulbumol 2.0mg, Tablet Albendox 400mg, Tablet Mebendox 100mg, Tablet I-Fol Plus, Tablet I-Fol, Tablet Indosin, Tablet Indo-Fila 100mg, Tablet Indomol Plus, Tablet Trialugel and Tablet ICet 10mg.

Number of employees: 194

Sales per Business

BDT in Million2022Weight2023Weight Delta
Medicine (Excluding Antibiotic), Medical Preparations Drugs and Chemicals (Human Health)
100.0 %
485 100.0 % 374 100.0 % -22.74%

Sales per region

BDT in Million2022Weight2023Weight Delta
Bangladesh
100.0 %
485 100.0 % 374 100.0 % -22.74%

Managers

Managers TitleAgeSince
A.F.M Anowarul Huq CEO
 Chief Executive Officer - 13-12-31
Mohammed Abu Taleb CMP
 Compliance Officer - -
Mizanur Rahaman ADM
 Chief Administrative Officer - 14-06-17
R. I. Chowdhury SAM
 Sales & Marketing - -
Mohi Uddin SEC
 Corporate Secretary - -

Members of the board

Members of the board TitleAgeSince
Mohammed Golam Rabbani BRD
 Director/Board Member 60 16-12-31
Aziza Yeasmin CHM
 Chairman 49 13-12-31
A.F.M Anowarul Huq CEO
 Chief Executive Officer - 13-12-31
Hafiza Yeasmin BRD
 Director/Board Member - 13-12-31

Company contact information

Indo-Bangla Pharmaceuticals Ltd.

Ahmed Akbar Sobhan Road Plot No. 183, 7th Floor, Block B

1229, Baridhara

+

http://www.indo-banglapharma.com
address Indo-Bangla Pharmaceuticals Limited(IBP)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sector Other Pharmaceuticals

1st Jan change Capi.
INDO-BANGLA PHARMACEUTICALS LIMITED Stock Indo-Bangla Pharmaceuticals Limited
-18.52% 15.2M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+60.59% 846B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+38.56% 628B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.34% 360B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.53% 322B
ABBVIE INC. Stock AbbVie Inc.
+9.22% 297B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.06% 240B
ROCHE HOLDING AG Stock Roche Holding AG
+2.94% 224B
NOVARTIS AG Stock Novartis AG
+16.93% 223B
AMGEN INC. Stock Amgen Inc.
+12.86% 173B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. IBP Stock
  4. Company Indo-Bangla Pharmaceuticals Limited